West Pharmaceutical Services Inc Capital Reinvestment Ratio

Latest as of March 2026: 0.47x

West Pharmaceutical Services Inc capital reinvestment ratio. West Pharmaceutical Services Inc (WST) has a Capital Reinvestment Ratio of 0.47x as of March 2026, meaning it reinvests 0% of its operating cash flow ($89.90 Million) in capital expenditures ($42.70 Million). See West Pharmaceutical Services Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.47x
Capex / Operating Cash Flow

Operating Cash Flow

$89.90 Million
USD

Capital Expenditures

$42.70 Million
USD

Data as of

Mar 2026
Most recent filing

Capital Reinvestment Ratio of West Pharmaceutical Services Inc (1989–2025)

Capital reinvestment ratio of West Pharmaceutical Services Inc from 1989 to 2025. This chart tracks West Pharmaceutical Services Inc's Capital Reinvestment Ratio across 37 annual periods. See West Pharmaceutical Services Inc (WST) financial flexibility to measure the company's free cash flow as a share of total liabilities.

West Pharmaceutical Services Inc Capital Reinvestment Ratio by Year (1989–2025)

West Pharmaceutical Services Inc capital reinvestment ratio by year from 1989 to 2025. For the full cash flow conversion analysis, see WST cash generation efficiency.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.38x $754.80 Million $285.90 Million ▼ -34.4%
2024 0.58x $653.40 Million $377.00 Million ▲ +23.8%
2023 0.47x $776.50 Million $362.00 Million ▲ +18.6%
2022 0.39x $724.00 Million $284.60 Million ▼ -9.4%
2021 0.43x $584.00 Million $253.40 Million ▲ +17.6%
2020 0.37x $472.50 Million $174.40 Million ▲ +7.2%
2019 0.34x $367.20 Million $126.40 Million ▼ -5.1%
2018 0.36x $288.60 Million $104.70 Million ▼ -27.0%
2017 0.50x $263.30 Million $130.80 Million ▼ -36.0%
2016 0.78x $219.40 Million $170.20 Million ▲ +25.2%
2015 0.62x $212.40 Million $131.60 Million ▲ +1.1%
2014 0.61x $182.90 Million $112.10 Million ▼ -13.3%
2013 0.71x $220.50 Million $155.80 Million ▲ +0.3%
2012 0.70x $187.40 Million $132.00 Million ▼ -4.9%
2011 0.74x $130.70 Million $96.80 Million ▲ +38.8%
2010 0.53x $138.30 Million $73.80 Million ▼ -31.8%
2009 0.78x $137.70 Million $107.80 Million ▼ -24.0%
2008 1.03x $135.00 Million $139.10 Million ▲ +2.9%
2007 1.00x $129.20 Million $129.40 Million ▲ +59.5%
2006 0.63x $143.80 Million $90.30 Million ▼ -0.6%
2005 0.63x $85.60 Million $54.10 Million ▼ -24.1%
2004 0.83x $68.90 Million $57.40 Million ▼ -5.2%
2003 0.88x $69.20 Million $60.80 Million ▲ +25.6%
2002 0.70x $53.90 Million $37.70 Million ▼ -48.1%
2001 1.35x $32.70 Million $44.10 Million ▲ +14.4%
2000 1.18x $48.60 Million $57.30 Million ▲ +29.1%
1999 0.91x $69.40 Million $63.40 Million ▼ -15.4%
1998 1.08x $71.00 Million $76.70 Million ▲ +112.6%
1997 0.51x $67.70 Million $34.40 Million ▲ +1.6%
1996 0.50x $63.40 Million $31.70 Million ▼ -26.4%
1995 0.68x $46.10 Million $31.30 Million ▲ +24.8%
1994 0.54x $49.80 Million $27.10 Million ▼ -37.5%
1993 0.87x $38.50 Million $33.50 Million ▲ +32.1%
1992 0.66x $34.00 Million $22.40 Million ▲ +14.7%
1991 0.57x $44.40 Million $25.50 Million ▼ -37.7%
1990 0.92x $36.00 Million $33.20 Million ▲ +15.3%
1989 0.80x $42.90 Million $34.30 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow